跳至主要内容
临床试验/IRCT20240131060870N1
IRCT20240131060870N1尚未招募1 期

Safety of Intranasal Spray Containing the Conditioned Medium of Mesenchymal Stem Cells Derived from Umbilical Cord Wharton's jelly in Alzheimer's Disease (Mild to Moderate) in phase 1 of a clinical trial

Iran University of Medical Sciences0 个研究点目标入组 9 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
入组人数
9

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
60 years 至 85 years(—)
性别
All

入选标准

  • Patients who have brain structural changes based on MRI and doctor's diagnosis, which confirms their Alzheimer's dementia.
  • Gender and Age: men and women between 60 and 85 Y.
  • Diagnosis of Mild to Moderate Alzheimer's dementia at least 6 months before the start of the study.
  • MMSE (Mini-Mental State Examination) Score: 10 and 24 at the time of starting the study

排除标准

  • Cancer patients who have been diagnosed in the last 5 years.
  • Patients who cannot undergo MRI due to their condition.
  • People with mental disorders
  • Have diseases such as vitamin B12 deficiency, diabetes, hypo/hyperthyroidism, and hepatitis.
  • History of cell therapy in the last 6 months.
  • Subjects who have participated in another clinical study within 3 months before the start of this study.
  • History of brain neoplasm.

研究者

相似试验